0 Beoordelingen
ID

22474

Beschrijving

Study part: .A Phase 2 Multicenter, Double-blind, Placebo-controlled, Study to to Evaluate the Corticosteroid- sparing effects of Mepolizumab in Subjects with Hypereosinophilic Syndromes (HES) and Evaluate Efficacy and Safety of Mepolizumab in Controlling the Clinical Signs and Symptoms of subjects with HES Patient Level Data: Study Listed on ClinicalStudyDataRequest.com. Sponsor: GlaxoSmithKline. Study ID: 100185, Clinical Study ID:MHE100185.

Trefwoorden

Versies (1)
  1. 05/06/2017 05/06/2017 -
Houder van rechten

GlaxoSmithKline

Geüploaded op

5 juin 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY-NC 3.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

  • Nieuwste
  • Oudste
  • Populair
  • Nieuwste
    • Nieuwste
    • Oudste
    • Populair

    Geen commentaren

    U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

    Serious Adverse Events Mepolizumab HES NCT00086658

    Engels

    Serious Adverse Events

    1 Formulieren  
    1. StudyEvent: ODM
      1. Serious Adverse Events
    SERIOUS ADVERSE EVENT (SAE)
    Beschrijving

    SERIOUS ADVERSE EVENT (SAE)

    Alias
    UMLS CUI-1
    C1519255
    Subject ID
    Beschrijving

    Subject ID

    Datatype

    text

    Alias
    UMLS CUI [1]
    C2348585
    Centre Number
    Beschrijving

    Centre Number

    Datatype

    integer

    Alias
    UMLS CUI [1,1]
    C0475309
    UMLS CUI [1,2]
    C0019994
    Randomisation Number
    Beschrijving

    Randomisation Number

    Datatype

    text

    Alias
    UMLS CUI [1,1]
    C0034656
    UMLS CUI [1,2]
    C0237753
    Did the subject experience a serious adverse event during the study?
    Beschrijving

    Serious Adverse Events

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C1519255
    SECTION 1
    Beschrijving

    SECTION 1

    Alias
    UMLS CUI-1
    C1828479
    Event
    Beschrijving

    Event

    Datatype

    text

    Alias
    UMLS CUI [1]
    C0877248
    Start Date
    Beschrijving

    Start Date

    Datatype

    date

    Alias
    UMLS CUI [1]
    C0808070
    Outcome
    Beschrijving

    Outcome

    Datatype

    integer

    Alias
    UMLS CUI [1]
    C1705586
    End date
    Beschrijving

    End date

    Datatype

    date

    Alias
    UMLS CUI [1]
    C0806020
    Maximum Intensity
    Beschrijving

    Maximum Intensity

    Datatype

    text

    Alias
    UMLS CUI [1,1]
    C0518690
    UMLS CUI [1,2]
    C0877248
    Action Taken with Investigational Product(s) as a Result of the SAE
    Beschrijving

    Action Taken

    Datatype

    text

    Alias
    UMLS CUI [1]
    C2826626
    Did the subject withdraw from study as a result of this SAE?
    Beschrijving

    Complete Study Conclusion page and Adverse event as reason for withdrawal.

    Datatype

    boolean

    Alias
    UMLS CUI [1,1]
    C2349954
    UMLS CUI [1,2]
    C1519255
    Is there a reasonable possibility the SAE may have been caused by the investigational product?
    Beschrijving

    causations adverse events

    Datatype

    boolean

    Alias
    UMLS CUI [1,1]
    C0085978
    UMLS CUI [1,2]
    C0877248
    If fatal, was a post-mortem/autopsy performed?
    Beschrijving

    If Yes, summarise findings in Section 11 Narrative Remarks of this SAE form.

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C0004398
    SECTION 2 Seriousness
    Beschrijving

    SECTION 2 Seriousness

    Alias
    UMLS CUI-1
    C1828479
    UMLS CUI-2
    C1710056
    Results in death
    Beschrijving

    Death

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C0011065
    Is life-threatening
    Beschrijving

    life-threatening

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C2826244
    Requires hospitalisation or prolongation of existing hospitalisation
    Beschrijving

    hospitalisation

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C0019993
    Results in disability/incapacity
    Beschrijving

    disability

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C0231170
    Congenital anomaly/birth defect
    Beschrijving

    Congenital anomaly

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C2826727
    Other, specify
    Beschrijving

    Other

    Datatype

    text

    Alias
    UMLS CUI [1]
    C0205394
    SECTION 3 Demography Data
    Beschrijving

    SECTION 3 Demography Data

    Alias
    UMLS CUI-1
    C1828479
    UMLS CUI-2
    C0011298
    Date of birth
    Beschrijving

    Date of birth

    Datatype

    date

    Alias
    UMLS CUI [1]
    C0421451
    Sex
    Beschrijving

    Sex

    Datatype

    text

    Alias
    UMLS CUI [1]
    C0079399
    Weight
    Beschrijving

    Weight

    Datatype

    float

    Maateenheden
    • kg
    kg
    SECTION 4
    Beschrijving

    SECTION 4

    Alias
    UMLS CUI-1
    C1828479
    If Investigational Product(s) was Stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were Administered?
    Beschrijving

    Adverse event Recurrence

    Datatype

    text

    Alias
    UMLS CUI [1,1]
    C0877248
    UMLS CUI [1,2]
    C0034897
    SECTION 5 Possible Causes of SAE Other Than Investigational Product(s)
    Beschrijving

    SECTION 5 Possible Causes of SAE Other Than Investigational Product(s)

    Alias
    UMLS CUI-1
    C1828479
    UMLS CUI-2
    C0085978
    UMLS CUI-3
    C1710056
    Disease under study
    Beschrijving

    Disease

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C0012634
    Medical condition(s) (record in Section 6)
    Beschrijving

    Medical condition

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C1699700
    Lack of efficacy
    Beschrijving

    Lack of efficacy

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C0235828
    Withdrawal of investigational product(s)
    Beschrijving

    Withdrawal of investigational product

    Datatype

    boolean

    Alias
    UMLS CUI [1,1]
    C2349954
    UMLS CUI [1,2]
    C0013227
    Concomitant medication (record in Section 8)
    Beschrijving

    Concomitant medication

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C2347852
    Activity related to study participation (e.g., procedures)
    Beschrijving

    study participation status

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C2348568
    Other, specify
    Beschrijving

    other

    Datatype

    text

    Alias
    UMLS CUI [1]
    C0205394
    SECTION 6 RELEVANT Medical Conditions
    Beschrijving

    SECTION 6 RELEVANT Medical Conditions

    Alias
    UMLS CUI-1
    C1828479
    UMLS CUI-2
    C0012634
    Specify any RELEVANT past or current medical disorders, allergies,surgeries, etc. that can help explain the SAE
    Beschrijving

    Medical Conditions Hypersensitivity surgeries

    Datatype

    text

    Alias
    UMLS CUI [1,1]
    C0012634
    UMLS CUI [1,2]
    C0020517
    UMLS CUI [1,3]
    C0543467
    Date of Onset
    Beschrijving

    Date of Onset

    Datatype

    date

    Alias
    UMLS CUI [1]
    C0574845
    Condition Present at Time of the SAE?
    Beschrijving

    Medical Conditions SAE

    Datatype

    boolean

    Alias
    UMLS CUI [1,1]
    C0012634
    UMLS CUI [1,2]
    C1519255
    If No, Date of Last Occurrence
    Beschrijving

    Date of Last Occurrence

    Datatype

    date

    Alias
    UMLS CUI [1,1]
    C2745955
    UMLS CUI [1,2]
    C0011008
    SECTION 7 Other RELEVANT Risk Factors
    Beschrijving

    SECTION 7 Other RELEVANT Risk Factors

    Alias
    UMLS CUI-1
    C1828479
    UMLS CUI-2
    C0035648
    Other RELEVANT Risk Factors (provide any family or social history (e.g., smoking, alcohol, diet, drug abuse, occupational hazard) relevant to the SAE)
    Beschrijving

    Risk Factors substance use disorder occupational hazard

    Datatype

    text

    Alias
    UMLS CUI [1,1]
    C0035648
    UMLS CUI [1,2]
    C0038586
    UMLS CUI [1,3]
    C0337074
    SECTION 8 RELEVANT Concomitant Medications
    Beschrijving

    SECTION 8 RELEVANT Concomitant Medications

    Alias
    UMLS CUI-1
    C1828479
    UMLS CUI-2
    C2347852
    Drug Name
    Beschrijving

    Drug Name

    Datatype

    text

    Alias
    UMLS CUI [1]
    C0013227
    Dose
    Beschrijving

    Dose

    Datatype

    integer

    Alias
    UMLS CUI [1]
    C3174092
    Unit
    Beschrijving

    Unit

    Datatype

    text

    Alias
    UMLS CUI [1]
    C1519795
    Frequency
    Beschrijving

    Frequency

    Datatype

    text

    Alias
    UMLS CUI [1]
    C3476109
    Route
    Beschrijving

    Route

    Datatype

    text

    Alias
    UMLS CUI [1]
    C0013153
    Taken Prior to Study?
    Beschrijving

    Taken Prior to Study?

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C2826667
    Start Date
    Beschrijving

    Start Date

    Datatype

    date

    Alias
    UMLS CUI [1]
    C0808070
    Stop Date
    Beschrijving

    Stop Date

    Datatype

    date

    Alias
    UMLS CUI [1]
    C0806020
    Ongoing Medication?
    Beschrijving

    Ongoing Medication?

    Datatype

    boolean

    Alias
    UMLS CUI [1]
    C2826666
    Reason for Medication
    Beschrijving

    Reason for Medication

    Datatype

    text

    Alias
    UMLS CUI [1,1]
    C0392360
    UMLS CUI [1,2]
    C0013227
    SECTION 9 Details of Investigational Product(s)
    Beschrijving

    SECTION 9 Details of Investigational Product(s)

    Alias
    UMLS CUI-1
    C1828479
    Did the SAE occur during the Screening Period?
    Beschrijving

    SAE Screening Study

    Datatype

    boolean

    Alias
    UMLS CUI [1,1]
    C1519255
    UMLS CUI [1,2]
    C2348164
    Date of First Dose
    Beschrijving

    Date of First Dose

    Datatype

    date

    Alias
    UMLS CUI [1]
    C3173309
    Date of Most Recent Dose
    Beschrijving

    Date of Most Recent Dose

    Datatype

    date

    Alias
    UMLS CUI [1,1]
    C0011008
    UMLS CUI [1,2]
    C3854006
    UMLS CUI [1,3]
    C1513491
    UMLS CUI [1,4]
    C0178602
    Number of Doses Completed to Date
    Beschrijving

    Number of Doses

    Datatype

    integer

    Alias
    UMLS CUI [1,1]
    C0178602
    UMLS CUI [1,2]
    C0750480
    Was randomisation code broken at investigational site?
    Beschrijving

    randomisation

    Datatype

    text

    Alias
    UMLS CUI [1]
    C0034656
    SECTION 10 Details of RELEVANT Assessments
    Beschrijving

    SECTION 10 Details of RELEVANT Assessments

    Alias
    UMLS CUI-1
    C1828479
    Details of RELEVANT Assessments (provide details of any other tests/procedures which were carried out to diagnose or confirm the SAE e.g.,laboratory data with units and normal range)
    Beschrijving

    Procedures related to diagnosis SAE laboratory

    Datatype

    text

    Alias
    UMLS CUI [1,1]
    C2939431
    UMLS CUI [1,2]
    C1519255
    UMLS CUI [1,3]
    C0022885
    SECTION 11 Narrative Remarks
    Beschrijving

    SECTION 11 Narrative Remarks

    Alias
    UMLS CUI-1
    C1828479
    Narrative Remarks (provide a brief narrative description of the SAE and details of treatment given)
    Beschrijving

    comment SAE

    Datatype

    text

    Alias
    UMLS CUI [1,1]
    C0947611
    UMLS CUI [1,2]
    C1519255
    Investigator’s signature
    Beschrijving

    Investigator signature

    Datatype

    text

    Alias
    UMLS CUI [1]
    C2346576
    Investigator’s name
    Beschrijving

    Investigator name

    Datatype

    text

    Alias
    UMLS CUI [1]
    C2826892
    Date
    Beschrijving

    Date

    Datatype

    date

    Alias
    UMLS CUI [1]
    C0011008
    Terug naar het begin van de pagina

    Similar models

    Serious Adverse Events

    1 Formulieren
    1. StudyEvent: ODM
      1. Serious Adverse Events
    Name
    Type
    Description | Question | Decode (Coded Value)
    Datatype
    Alias
    Item Group
    SERIOUS ADVERSE EVENT (SAE)
    C1519255 (UMLS CUI-1)
    Subject ID
    Item
    Subject ID
    text
    C2348585 (UMLS CUI [1])
    Centre Number
    Item
    Centre Number
    integer
    C0475309 (UMLS CUI [1,1])
    C0019994 (UMLS CUI [1,2])
    Randomisation Number
    Item
    Randomisation Number
    text
    C0034656 (UMLS CUI [1,1])
    C0237753 (UMLS CUI [1,2])
    Serious Adverse Events
    Item
    Did the subject experience a serious adverse event during the study?
    boolean
    C1519255 (UMLS CUI [1])
    Item Group
    SECTION 1
    C1828479 (UMLS CUI-1)
    Event
    Item
    Event
    text
    C0877248 (UMLS CUI [1])
    Start Date
    Item
    Start Date
    date
    C0808070 (UMLS CUI [1])
    Item
    Outcome
    integer
    C1705586 (UMLS CUI [1])
    Outcome
    Code List
    Outcome
    CL Item
    Recovered/Resolved (1)
    CL Item
    Recovering/Resolving (2)
    CL Item
    Not recovered/Not resolved (3)
    CL Item
    Recovered/Resolved with sequelae (4)
    CL Item
    Fatal (5)
    End date
    Item
    End date
    date
    C0806020 (UMLS CUI [1])
    Item
    Maximum Intensity
    text
    C0518690 (UMLS CUI [1,1])
    C0877248 (UMLS CUI [1,2])
    Maximum Intensity
    Code List
    Maximum Intensity
    CL Item
    Mild (Mild)
    CL Item
    Moderate (Moderate)
    CL Item
    Severe (Severe)
    CL Item
    Not applicable (Not applicable)
    Item
    Action Taken with Investigational Product(s) as a Result of the SAE
    text
    C2826626 (UMLS CUI [1])
    Action Taken
    Code List
    Action Taken with Investigational Product(s) as a Result of the SAE
    CL Item
    Investigational product(s) withdrawn (Investigational product(s) withdrawn)
    CL Item
    Dose reduced (Dose reduced)
    CL Item
    Dose increased (Dose increased)
    CL Item
    Dose not changed (Dose not changed)
    CL Item
    Dose interrupted (Dose interrupted)
    CL Item
    Not applicable (Not applicable)
    subject withdraw from study as a result of SAE
    Item
    Did the subject withdraw from study as a result of this SAE?
    boolean
    C2349954 (UMLS CUI [1,1])
    C1519255 (UMLS CUI [1,2])
    causations adverse events
    Item
    Is there a reasonable possibility the SAE may have been caused by the investigational product?
    boolean
    C0085978 (UMLS CUI [1,1])
    C0877248 (UMLS CUI [1,2])
    autopsy
    Item
    If fatal, was a post-mortem/autopsy performed?
    boolean
    C0004398 (UMLS CUI [1])
    Item Group
    SECTION 2 Seriousness
    C1828479 (UMLS CUI-1)
    C1710056 (UMLS CUI-2)
    Death
    Item
    Results in death
    boolean
    C0011065 (UMLS CUI [1])
    life-threatening
    Item
    Is life-threatening
    boolean
    C2826244 (UMLS CUI [1])
    hospitalisation
    Item
    Requires hospitalisation or prolongation of existing hospitalisation
    boolean
    C0019993 (UMLS CUI [1])
    disability
    Item
    Results in disability/incapacity
    boolean
    C0231170 (UMLS CUI [1])
    Congenital anomaly
    Item
    Congenital anomaly/birth defect
    boolean
    C2826727 (UMLS CUI [1])
    Other
    Item
    Other, specify
    text
    C0205394 (UMLS CUI [1])
    Item Group
    SECTION 3 Demography Data
    C1828479 (UMLS CUI-1)
    C0011298 (UMLS CUI-2)
    Date of birth
    Item
    Date of birth
    date
    C0421451 (UMLS CUI [1])
    Item
    Sex
    text
    C0079399 (UMLS CUI [1])
    Sex
    Code List
    Sex
    CL Item
    Male (Male)
    CL Item
    Female (Female)
    Weight
    Item
    Weight
    float
    Item Group
    SECTION 4
    C1828479 (UMLS CUI-1)
    Item
    If Investigational Product(s) was Stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were Administered?
    text
    C0877248 (UMLS CUI [1,1])
    C0034897 (UMLS CUI [1,2])
    Adverse event Recurrence
    Code List
    If Investigational Product(s) was Stopped, Did the Reported Event(s) Recur After Further Investigational Product(s) were Administered?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    CL Item
    Unknown at this time (Unknown at this time)
    CL Item
    Not applicable (Not applicable)
    Item Group
    SECTION 5 Possible Causes of SAE Other Than Investigational Product(s)
    C1828479 (UMLS CUI-1)
    C0085978 (UMLS CUI-2)
    C1710056 (UMLS CUI-3)
    Disease
    Item
    Disease under study
    boolean
    C0012634 (UMLS CUI [1])
    Medical condition
    Item
    Medical condition(s) (record in Section 6)
    boolean
    C1699700 (UMLS CUI [1])
    Lack of efficacy
    Item
    Lack of efficacy
    boolean
    C0235828 (UMLS CUI [1])
    Withdrawal of investigational product
    Item
    Withdrawal of investigational product(s)
    boolean
    C2349954 (UMLS CUI [1,1])
    C0013227 (UMLS CUI [1,2])
    Concomitant medication
    Item
    Concomitant medication (record in Section 8)
    boolean
    C2347852 (UMLS CUI [1])
    study participation status
    Item
    Activity related to study participation (e.g., procedures)
    boolean
    C2348568 (UMLS CUI [1])
    other
    Item
    Other, specify
    text
    C0205394 (UMLS CUI [1])
    Item Group
    SECTION 6 RELEVANT Medical Conditions
    C1828479 (UMLS CUI-1)
    C0012634 (UMLS CUI-2)
    Medical Conditions Hypersensitivity surgeries
    Item
    Specify any RELEVANT past or current medical disorders, allergies,surgeries, etc. that can help explain the SAE
    text
    C0012634 (UMLS CUI [1,1])
    C0020517 (UMLS CUI [1,2])
    C0543467 (UMLS CUI [1,3])
    Date of Onset
    Item
    Date of Onset
    date
    C0574845 (UMLS CUI [1])
    Medical Conditions SAE
    Item
    Condition Present at Time of the SAE?
    boolean
    C0012634 (UMLS CUI [1,1])
    C1519255 (UMLS CUI [1,2])
    Date of Last Occurrence
    Item
    If No, Date of Last Occurrence
    date
    C2745955 (UMLS CUI [1,1])
    C0011008 (UMLS CUI [1,2])
    Item Group
    SECTION 7 Other RELEVANT Risk Factors
    C1828479 (UMLS CUI-1)
    C0035648 (UMLS CUI-2)
    Risk Factors substance use disorder occupational hazard
    Item
    Other RELEVANT Risk Factors (provide any family or social history (e.g., smoking, alcohol, diet, drug abuse, occupational hazard) relevant to the SAE)
    text
    C0035648 (UMLS CUI [1,1])
    C0038586 (UMLS CUI [1,2])
    C0337074 (UMLS CUI [1,3])
    Item Group
    SECTION 8 RELEVANT Concomitant Medications
    C1828479 (UMLS CUI-1)
    C2347852 (UMLS CUI-2)
    Drug Name
    Item
    Drug Name
    text
    C0013227 (UMLS CUI [1])
    Dose
    Item
    Dose
    integer
    C3174092 (UMLS CUI [1])
    Unit
    Item
    Unit
    text
    C1519795 (UMLS CUI [1])
    Frequency
    Item
    Frequency
    text
    C3476109 (UMLS CUI [1])
    Route
    Item
    Route
    text
    C0013153 (UMLS CUI [1])
    Taken Prior to Study?
    Item
    Taken Prior to Study?
    boolean
    C2826667 (UMLS CUI [1])
    Start Date
    Item
    Start Date
    date
    C0808070 (UMLS CUI [1])
    Stop Date
    Item
    Stop Date
    date
    C0806020 (UMLS CUI [1])
    Ongoing Medication?
    Item
    Ongoing Medication?
    boolean
    C2826666 (UMLS CUI [1])
    Reason for Medication
    Item
    Reason for Medication
    text
    C0392360 (UMLS CUI [1,1])
    C0013227 (UMLS CUI [1,2])
    Item Group
    SECTION 9 Details of Investigational Product(s)
    C1828479 (UMLS CUI-1)
    SAE Screening Study
    Item
    Did the SAE occur during the Screening Period?
    boolean
    C1519255 (UMLS CUI [1,1])
    C2348164 (UMLS CUI [1,2])
    Date of First Dose
    Item
    Date of First Dose
    date
    C3173309 (UMLS CUI [1])
    Date of Most Recent Dose
    Item
    Date of Most Recent Dose
    date
    C0011008 (UMLS CUI [1,1])
    C3854006 (UMLS CUI [1,2])
    C1513491 (UMLS CUI [1,3])
    C0178602 (UMLS CUI [1,4])
    Number of Doses
    Item
    Number of Doses Completed to Date
    integer
    C0178602 (UMLS CUI [1,1])
    C0750480 (UMLS CUI [1,2])
    Item
    Was randomisation code broken at investigational site?
    text
    C0034656 (UMLS CUI [1])
    randomisation
    Code List
    Was randomisation code broken at investigational site?
    CL Item
    Yes (Yes)
    CL Item
    No (No)
    CL Item
    Not applicable (Not applicable)
    Item Group
    SECTION 10 Details of RELEVANT Assessments
    C1828479 (UMLS CUI-1)
    Procedures related to diagnosis SAE laboratory
    Item
    Details of RELEVANT Assessments (provide details of any other tests/procedures which were carried out to diagnose or confirm the SAE e.g.,laboratory data with units and normal range)
    text
    C2939431 (UMLS CUI [1,1])
    C1519255 (UMLS CUI [1,2])
    C0022885 (UMLS CUI [1,3])
    Item Group
    SECTION 11 Narrative Remarks
    C1828479 (UMLS CUI-1)
    comment SAE
    Item
    Narrative Remarks (provide a brief narrative description of the SAE and details of treatment given)
    text
    C0947611 (UMLS CUI [1,1])
    C1519255 (UMLS CUI [1,2])
    Investigator signature
    Item
    Investigator’s signature
    text
    C2346576 (UMLS CUI [1])
    Investigator name
    Item
    Investigator’s name
    text
    C2826892 (UMLS CUI [1])
    Date
    Item
    Date
    date
    C0011008 (UMLS CUI [1])
    Terug naar het begin van de pagina 

    Help

    Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

    Watch Tutorial